Literature DB >> 19619095

Do Team Care Arrangements address the real issues in the management of chronic disease?

Paul A Hartigan1, Tuck Meng Soo, Marjan Kljakovic.   

Abstract

Care plans are a decade-old program for coordinating care of patients with chronic illness. The program currently involves Team Care Arrangements (TCAs), which require all providers to agree on all management decisions contained in the plan. By contrast, conventional referral processes leave it to providers to exercise their judgement about the other providers to be involved. TCA requirements make coordination unwieldy and lack an evidentiary basis. More importantly, although care plans were introduced to encourage general practitioners to shift from an episodic to a global approach, they do not necessarily do this. The care plan objective would be better served by the development of comprehensive patient summaries.

Entities:  

Mesh:

Year:  2009        PMID: 19619095     DOI: 10.5694/j.1326-5377.2009.tb02702.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

1.  Involvement of practice nurses and allied health professionals in the development and management of care planning processes for patients with chronic disease - A pilot study.

Authors:  Km Jones; A Adaji; Ps Schattner
Journal:  Malays Fam Physician       Date:  2014-04-30

2.  'The onus is on me': primary care patient views of Medicare-funded team care in chronic disease management in Australia.

Authors:  Michele M Foster; Geoffrey K Mitchell
Journal:  Health Expect       Date:  2013-03-22       Impact factor: 3.377

3.  Footing the bill: the introduction of Medicare Benefits Schedule rebates for podiatry services in Australia.

Authors:  Anthony J Short
Journal:  J Foot Ankle Res       Date:  2009-12-07       Impact factor: 2.303

4.  Utilisation of podiatry services in Australia under the Medicare Enhanced Primary Care program, 2004-2008.

Authors:  Hylton B Menz
Journal:  J Foot Ankle Res       Date:  2009-10-30       Impact factor: 2.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.